Delayed
Nasdaq
01:56:26 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
0.8201
USD
|
-3.63%
|
|
-4.64%
|
-67.97%
|
Fiscal Period: June |
2023
|
---|
Capitalization
1 |
18.79
|
Enterprise Value (EV)
1 |
18.91
|
P/E ratio
|
-1.63
x
|
Yield
|
-
|
Capitalization / Revenue
|
2,666,376,419
x
|
EV / Revenue
|
2,682,682,605
x
|
EV / EBITDA
|
-
|
EV / FCF
|
-2,748,545
x
|
FCF Yield
|
-0%
|
Price to Book
|
4.29
x
|
Nbr of stocks (in thousands)
|
1,634
|
Reference price
2 |
11.50
|
Announcement Date
|
10/13/23
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
0.007048
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.8454
|
-2.512
|
-3.469
|
-5.765
|
Operating Margin
|
-
|
-
|
-
|
-81,800.98%
|
Earnings before Tax (EBT)
1 |
-1.16
|
-4.726
|
-5.856
|
-8.988
|
Net income
1 |
-1.16
|
-4.726
|
-5.856
|
-8.988
|
Net margin
|
-
|
-
|
-
|
-127,532.01%
|
EPS
2 |
-2.511
|
-8.810
|
-6.797
|
-7.077
|
Free Cash Flow
|
-
|
-3.017
|
-2.178
|
-6.879
|
FCF margin
|
-
|
-
|
-
|
-97,603.75%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/28/21
|
1/21/22
|
11/14/22
|
10/13/23
|
Fiscal Period: June |
2023 Q4
|
2024 Q1
|
2024 Q2
|
---|
Net sales
1 |
0.00705
|
-
|
0.00968
|
EBITDA
|
-2.072
|
-1.463
|
-
|
EBIT
1 |
-2.1
|
-1.51
|
-0.8683
|
Operating Margin
|
-29,790.64%
|
-
|
-8,970.35%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
10/13/23
|
11/13/23
|
2/13/24
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1.22
|
1.95
|
4.77
|
0.11
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-3.02
|
-2.18
|
-6.88
|
ROE (net income / shareholders' equity)
|
-
|
88.4%
|
105%
|
18,147%
|
ROA (Net income/ Total Assets)
|
-
|
-55.3%
|
-42.6%
|
-53.7%
|
Assets
1 |
-
|
8.542
|
13.75
|
16.73
|
Book Value Per Share
2 |
-0.9300
|
-0.9800
|
-4.580
|
2.680
|
Cash Flow per Share
2 |
0.0100
|
0.0400
|
0.0500
|
0.9600
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/28/21
|
1/21/22
|
11/14/22
|
10/13/23
|
|
1st Jan change
|
Capi.
|
---|
| -67.97% | 1.5M | | +43.38% | 749B | | +39.42% | 605B | | -6.57% | 351B | | +18.96% | 328B | | +8.12% | 292B | | +11.92% | 216B | | -2.62% | 214B | | +0.19% | 167B | | +6.10% | 165B |
Other Pharmaceuticals
|